Modulators of protein tyrosine phosphatases (PTPases)
US6225329A · kind A · utility
Assignee
Inventors
Key dates
| Filing date | Mar 9, 1999 |
| Grant date | May 1, 2001 |
| Priority date | — |
| Expiry date | Mar 9, 2019 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D271/07
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention provides novel compounds of Formula 1, compositions containing these compounds, methods of their use, and methods of their manufacture, where such compounds are pharmacologically useful inhibitors of Protein Tyrosine Phosphatases (PTPase's) such as PTP1B, CD45, SHP-1, SHP-2, PTP.alpha., LAR and HePTP or the like, ##STR1## wherein A, R.sub.1, R.sub.2, R.sub.3, R.sub.4, R.sub.16 and R.sub.17 are as defined in the specification. The compounds are useful in the treatment of type I diabetes, type II diabetes, impaired glucose tolerance, insulin resistance, obesity, immune dysfunctions including autoimmunity diseases with dysfunctions of the coagulation system, allergic diseases including asthma, osteoporosis, proliferative disorders including cancer and psoriasis, diseases with decreased or increased synthesis or effects of growth hormone, diseases with decreased or increased synthesis of hormones or cytokines that regulate the release of/or response to growth hormone, diseases of the brain including Alzheimer's disease and schizophrenia, and infectious diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.